Page 302 - Read Online

Page 16 of 16 Thirugnanam et al. Vessel Plus 2020;4:26 I http://dx.doi.org/10.20517/2574-1209.2020.18

Cell Cardiol 2013;63:98-106.
84. Gottlieb RA, Bernstein D. METABOLISM. Mitochondria shape cardiac metabolism. Science 2015;350:1162-3.
85. Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT, D’Antoni ML, et al. Revisiting cardiac cellular composition. Circ Res 2016;118:400-9.
86. Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine
166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2010;2:914-23.
87. Pillai VB, Samant S, Sundaresan NR, Raghuraman H, Kim G, et al. Honokiol blocks and reverses cardiac hypertrophy in mice by
activating mitochondrial Sirt3. Nat Commun 2015;6:6656.
88. Pillai VB, Kanwal A, Fang YH, Sharp WW, Samant S, et al. Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and
protects the heart from doxorubicin-induced cardiomyopathy in mice. Oncotarget 2017;8:34082-98.
89. Chen L, Chen R, Wang H, Liang F. Mechanisms Linking Inflammation to Insulin Resistance. Int J Endocrinol 2015;2015:508409.
90. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
91. Avizienyte E, Loukola A, Roth S, Hemminki A, Tarkkanen M, et al. LKB1 somatic mutations in sporadic tumors. Am J Pathol
1999;154:677-81.
92. Bignell GR, Barfoot R, Seal S, Collins N, Warren W, et al. Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome
gene in sporadic breast cancer. Cancer Res 1998;58:1384-6.
93. Su GH, Hruban RH, Bansal RK, Bova GS, Tang DJ, et al. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in
pancreatic and biliary cancers. Am J Pathol 1999;154:1835-40.
94. Rowan A, Bataille V, MacKie R, Healy E, Bicknell D, et al. Somatic mutations in the Peutz-Jeghers [LKB1/STKII] gene in sporadic
malignant melanomas. J Invest Dermatol 1999;112:509-11.
95. Qiu W, Schönleben F, Thaker HM, Goggins M, Su GH. A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition
in head and neck squamous cell carcinoma. Oncogene 2006;25:2937-42.
96. Kim CJ, Cho YG, Park JY, Kim TY, Lee JH, et al. Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas. Eur J Cancer
2004;40:136-41.
97. Powis G, Kirkpatrick L. Hypoxia inducible factor-1alpha as a cancer drug target. Mol Cancer Ther 2004;3:647-54.
98. Nie F, Yu XL, Wang XG, Tang YF, Wang LL, et al. Down-regulation of CacyBP is associated with poor prognosis and the effects on
COX-2 expression in breast cancer. Int J Oncol 2010;37:1261-9.
99. Ning X, Sun S, Hong L, Liang J, Liu L, et al. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric
cancer. Mol Cancer Res 2007;5:1254-62.
100. Sun S, Ning X, Liu J, Liu L, Chen Y, et al. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma.
Biochem Biophys Res Commun 2007;356:864-71.
101. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, et al. Adipocytes promote ovarian cancer metastasis and provide
energy for rapid tumor growth. Nat Med 2011;17:1498-503.